Viewing Study NCT02014558


Ignite Creation Date: 2025-12-25 @ 12:15 AM
Ignite Modification Date: 2026-02-18 @ 6:47 PM
Study NCT ID: NCT02014558
Status: COMPLETED
Last Update Posted: 2024-12-03
First Post: 2013-11-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: Astellas Pharma Global Development, Inc.
Organization: